home / stock / valn / valn news


VALN News and Press, Valneva SE From 11/10/23

Stock Information

Company Name: Valneva SE
Stock Symbol: VALN
Market: NASDAQ

Menu

VALN VALN Quote VALN Short VALN News VALN Articles VALN Message Board
Get VALN Alerts

News, Short Squeeze, Breakout and More Instantly...

VALN - FDA approves Valneva's world-first chikungunya vaccine

2023-11-10 04:26:41 ET More on Valneva Valneva SE (VALN) Q3 2023 Earnings Call Transcript Valneva's Vaccination Valor: A Buy Rating Justified Valneva SE (VALN) Q2 2023 Earnings Call Transcript Valneva reports 9M results FDA finds no issues in Pfizer/ ...

VALN - Valneva SE (VALN) Q3 2023 Earnings Call Transcript

2023-11-09 14:15:37 ET Valneva SE (VALN) Q3 2023 Earnings Conference Call November 09, 2023, 09:00 ET Company Participants Joshua Drumm - VP, IR Thomas Lingelbach - Chairman, President & CEO Peter Buhler - CFO Conference Call Participants Maurice ...

VALN - Expected US Company Earnings on Thursday, November 9th, 2023

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

VALN - FDA finds no issues in Pfizer/ Valneva Lyme disease vaccine trial

2023-10-11 14:10:27 ET More on Pfizer, Valneva, etc. Valneva's Vaccination Valor: A Buy Rating Justified Pfizer: Sell-Off Overdone, Healthy Pipeline To Sustain Above 15% ROE Pfizer Inc. (PFE) CEO Albert Bourla Presents at Cantor Fitzgerald Annual Global Health Confer...

VALN - Valneva's Vaccination Valor: A Buy Rating Justified

2023-10-04 23:45:21 ET Summary Valneva's 1H 2023 revenue declined compared to the previous year, but product sales more than doubled, driven by the recovery in the travel market. The phase 3 trial for VLA15, a Lyme disease vaccine candidate, is progressing well, with plans for off...

VALN - Valneva gets new $32M supply contract for the U.S. government

2023-09-25 01:55:01 ET More on Valneva Valneva: VLA1553 Takes The Lead In The Chikungunya Vaccine Race Pfizer, Valneva post Phase 2 booster data for Lyme disease vaccine Valneva falls as FDA extends review of chikungunya vaccine For further details see: V...

VALN - Valneva SE (VALN) Q2 2023 Earnings Call Transcript

2023-09-21 13:06:04 ET Valneva SE (VALN) Q2 2023 Earnings Conference Call September 21, 2023, 09:00 AM ET Company Participants Joshua Drumm - VP, IR Thomas Lingelbach - CEO Peter Buhler - CFO Conference Call Participants Maury Raycroft - Jefferies ...

VALN - Earnings week ahead: FedEx, General Mills, AutoZone and more

2023-09-17 08:00:00 ET Related stories Compare metrics for AZO to DRI, FDX, GIS, SFIX Reasons Why AutoZone Should Be On Your Watchlist AutoZone: Set Up For Another Good Decade General Mills, Inc. ( GIS ) Barclays 2023 Global Consumer Staples Conference ...

VALN - Expected US Company Earnings on Thursday, September 14th, 2023

Verbund AG ADR (OEZVY) is expected to report for Q2 2023 Adtran Networks SE (ADVOF) is expected to report for Q2 2023 OMV AG (OMVJF) is expected to report $1.66 for Q2 2023 Firm Capital Property Trust Unit (FRMUF) is expected to report for Q1 2024 Minim Inc (MINM) is expected to r...

VALN - Expected US Company Earnings on Thursday, September 7th, 2023

DocuSign Inc. (DOCU) is expected to report $0.11 for Q2 2024 Firm Capital Property Trust Unit (FRMUF) is expected to report for Q1 2024 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Concrete Pumping Holdings Inc. (BBCP) is expected to report $0.16 for Q3 2023 ...

Previous 10 Next 10